Analyst Ratings for Assembly Biosciences (ASMB)
ASMB Rating Summary
ASMB Price Target Summary
- Highest: $62.00 (Jefferies)
- Lowest: $43.00 (Guggenheim)
- Average: $50.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.40 (+150.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$50.40 (+150.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | UBS | Ashwani Verma | New Coverage | Buy (N/A) |
52.00 (N/A) |
34.07 (20.09) |
-41.03% | Details |
| 9/24/2025 | Citizens | Roy Buchanan | New Coverage | Market Outperform (N/A) |
38.00 (N/A) |
24.78 (20.09) |
-18.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
